Skip to content

Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months

Formulation and Production of Macro- and Micronutrient Sachets for Home Fortification and Evaluation of Their Efficacy on Pregnant Mothers and Children Aged 6-60 Months in Sistan Baloochestan

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05412238
Enrollment
20
Registered
2022-06-09
Start date
2022-09-30
Completion date
2023-02-28
Last updated
2022-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood, Pregnancy

Brief summary

The aim of the present study is formulation and production of sachets containing macronutrients and micronutrients to enrich food at home and evaluate its effectiveness on pregnant mothers and children aged 6 to 60 months living in Sistan and Baluchestan province

Detailed description

This study is conducted in three steps. At first, fortification sachets are formulated and produced in accordance with international recommendations for micronutrients (vitamins A, D, zinc, and iron) and macronutrients for use in normal home conditions. In the second step, efficacy of fortified sachets are evaluate in three subgroups including pregnant mothers, 6-24 months and 2-5 years old children. Nutritional, anthropometrical and biochemical indices are evaluated at the beginning and after 6-9 months intervention. At the third step, costs and cost-effectiveness of the intervention in each of the studied groups in comparison with the usual program for that age group in the health care system of the country is determined.

Interventions

DIETARY_SUPPLEMENTmicro-and macro-nutrients fortified sachets

Every subject receives daily fortified sachets containing micro-and macronutrients for 6-9 months

Sponsors

National Nutrition and Food Technology Institute
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Pregnant women * being in the first trimester of pregnancy * free of chronic diseases before pregnancy * no intention to change residence until delivery 2. Children 6 to 23 months * age 6 to 7 months * no intention to change residence or migrate in the next 12 months * free of acute or chronic illness 3. Children 2 to 5 years (60-24 months) * age 24 to 48 months * no intention to change residence or migrate in the next 6-12 months * free of acute or chronic diseases

Exclusion criteria

1. Pregnant women * premature termination of pregnancy * change of residence before delivery 2. Children 6 to 23 months -change of residence before delivery 3. Children 2 to 5 years (60-24 months) -change of residence before delivery

Design outcomes

Primary

MeasureTime frameDescription
Weight gain during pregnancy6-9 monthsWeight difference at the beginning and end of pregnancy
Birth weight6-9 monthsMeasured weight (kg) at the first day of life
Weight for age6-9 monthsMeasured weight (kg) in a specific age (year)
Weight for height6-9 monthsThe ratio of weight (kg) to height(m)

Secondary

MeasureTime frameDescription
Serum retinol (micromol/L)6-9 monthsFasting serum retinol level
Serum folate (ng/mL)6-9 monthsFasting serum folate level
25-hydroxyvitamin D (nmol/L)6-9 monthsFasting serum 25-hydroxyvitamin D level
Apgar score6-9 monthsThe Apgar score is a quick evaluation of one minute and five minutes after birth which tests the birthing process and readiness of newborn to meet the world without additional medical assistance
Serum B12 (pg/mL)6-9 monthsFasting serum B12 level
Hemoglobin (g/dL)6-9 monthsBlood hemoglobin level
Serum ferritin (ng/mL)6-9 monthsFasting serum ferritin level
Serum zinc (microg/dL)6-9 monthFasting serum zinc level

Countries

Iran

Contacts

Primary ContactTirang R. Neyestani, PhD
neytr@yahoo.com982122376471
Backup ContactBahareh Nikooyeh, PhD
nikooyeh11024@yahoo.com982122376471

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026